314140 — RP Bio lnc Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for RP Bio lnc, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	4,616	3,813	4,316	5,437	-907
Depreciation
Amortisation
Non-Cash Items	1,903	4,464	8,033	4,336	3,186
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-4,478	-4,021	-16,596	-5,241	4,426
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6,455	9,459	1,155	10,580	13,524
Capital Expenditures	-11,704	-7,271	-5,279	-11,164	-6,011
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	7,100	105	-660	-7,100	4,510
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-4,603	-7,166	-5,939	-18,264	-1,501
Financing Cash Flow Items	—	—	-502	-3.79	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	4,160	-3,392	15,332	-5,924	-1,098
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	6,011	-1,099	10,547	-13,608	10,925